Drugs / Solfenacin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT07447518 Comparator | Sep 2022 → Jan 2023 | — | Kafrelsheikh University | Completed | No outcome recorded |
| — | NCT06184334 Comparator | Sep → Dec 2022 | overactive bladder | Elsayed Abdelhalim Elsayed | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Solfenacin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07447518 ↗ |
| Route | Oral | “pills taken once day” NCT06184334 ↗ |